THE NEW PROSPECT FOR WEIGHT CONTROL ?

Scientists are rapidly investigating retatrutide, a novel drug developed by Eli Lilly, as a significant breakthrough in weight reduction . Distinct from many previous approaches, retatrutide is a twin-action receptor targeting both GLP-1 and GIP, substances that influence appetite and glucose ba